Immune Design Corp.
IMDZ
IMDZ was delisted on the 1st of April, 2019.
67 hedge funds and large institutions have $209M invested in Immune Design Corp. in 2015 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 24 increasing their positions, 17 reducing their positions, and 5 closing their positions.
180% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 5
41% more repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 17
25% more capital invested
Capital invested by funds: $167M → $209M (+$41.8M)
14% more funds holding
Funds holding: 59 → 67 (+8)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
85% less call options, than puts
Call options by funds: $20K | Put options by funds: $133K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$4.19M |
| 2 |
RIM
RS Investment Management
San Francisco,
California
|
+$2.12M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
+$1.31M |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$969K |
| 5 |
VIA
Vident Investment Advisory
Alpharetta,
Georgia
|
+$661K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$13.5M |
| 2 |
IHM
Iguana Healthcare Management
New York
|
-$915K |
| 3 |
NFA
Nationwide Fund Advisors
Columbus,
Ohio
|
-$424K |
| 4 |
Franklin Resources
San Mateo,
California
|
-$417K |
| 5 |
Goldman Sachs
New York
|
-$379K |
IMDZ Hedge Fund Activity: Q4 2015 in Review
67 of the 3,824 institutional investors tracked by Wall St. Rank reported a position in Immune Design Corp. (IMDZ) for Q4 2015, worth a combined $209M — up 25% from $167M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new IMDZ positions and 5 closed out — a net gain of 9 holders — while 24 added to existing stakes and 17 trimmed.
The largest buyer was BlackRock Fund Advisors, adding an estimated $4.19M. The largest seller was T. Rowe Price Associates, cutting an estimated $13.5M.
- 67 institutional investors held Immune Design Corp. (IMDZ) as of Q4 2015, up from 59 in Q3 2015.
- Funds reported $209M of Immune Design Corp. stock for Q4 2015, up 25% quarter-over-quarter.
- 14 funds opened new Immune Design Corp. positions in Q4 2015 and 5 closed out, a net change of +9 holders.
- The largest Immune Design Corp. buyer in Q4 2015 was BlackRock Fund Advisors, an estimated $4.19M added.
- The largest Immune Design Corp. seller in Q4 2015 was T. Rowe Price Associates, an estimated $13.5M sold.
Based on aggregated 13F filings for Q4 2015.